THC RSI Chart
Last 7 days
2.3%
Last 30 days
-4.3%
Last 90 days
18.9%
Trailing 12 Months
38.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 19.4B | 19.9B | 20.2B | 20.5B |
2022 | 19.4B | 19.1B | 19.0B | 19.2B |
2021 | 17.9B | 19.2B | 19.5B | 19.5B |
2020 | 18.5B | 17.5B | 17.5B | 17.6B |
2019 | 18.2B | 18.2B | 18.3B | 18.5B |
2018 | 20.1B | 19.4B | 19.0B | 18.3B |
2017 | 20.8B | 20.8B | 20.5B | 20.6B |
2016 | 20.7B | 21.1B | 21.3B | 21.1B |
2015 | 18.4B | 18.9B | 19.5B | 20.1B |
2014 | 13.8B | 15.5B | 17.3B | 17.9B |
2013 | 10.0B | 10.2B | 10.4B | 12.1B |
2012 | 9.4B | 9.6B | 9.7B | 9.9B |
2011 | 9.1B | 9.1B | 9.1B | 9.4B |
2010 | 8.9B | 8.9B | 8.9B | 9.0B |
2009 | 0 | 8.7B | 8.7B | 8.8B |
2008 | 0 | 0 | 0 | 8.6B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | sutaria saumya | gifted | - | - | -125,000 | chairman & ceo |
Mar 12, 2024 | mark richard j | sold | -1,385,720 | 98.98 | -14,000 | - |
Mar 06, 2024 | arbour paola m | sold | -1,761,570 | 96.96 | -18,168 | evp, chief information officer |
Mar 01, 2024 | sutaria saumya | acquired | - | - | 36,384 | chairman & ceo |
Mar 01, 2024 | arnst thomas w | sold | -1,612,230 | 94.8373 | -17,000 | evp, chief admin. officer & gc |
Mar 01, 2024 | arbour paola m | sold (taxes) | -103,908 | 94.29 | -1,102 | evp, chief information officer |
Mar 01, 2024 | arbour paola m | acquired | - | - | 2,799 | evp, chief information officer |
Mar 01, 2024 | ramsey r. scott | sold (taxes) | -32,152 | 94.29 | -341 | principal accounting officer |
Mar 01, 2024 | ramsey r. scott | acquired | - | - | 1,399 | principal accounting officer |
Mar 01, 2024 | arnst thomas w | acquired | - | - | 5,597 | evp, chief admin. officer & gc |
Which funds bought or sold THC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | WEDGE CAPITAL MANAGEMENT L L P/NC | added | 1,265 | 46,617,500 | 49,208,100 | 0.80% |
Apr 23, 2024 | Louisiana State Employees Retirement System | added | 2.46 | 915,467 | 3,069,210 | 0.06% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -10.61 | 1,419,000 | 7,251,000 | 0.06% |
Apr 23, 2024 | FIFTH THIRD BANCORP | added | 3.71 | 27,021 | 88,082 | -% |
Apr 23, 2024 | BFSG, LLC | reduced | -22.66 | 18,045 | 256,469 | 0.03% |
Apr 23, 2024 | Venturi Wealth Management, LLC | added | 388 | 7,440 | 8,725 | -% |
Apr 23, 2024 | Gradient Investments LLC | unchanged | - | 178 | 631 | -% |
Apr 23, 2024 | NEW MEXICO EDUCATIONAL RETIREMENT BOARD | unchanged | - | 602,000 | 2,144,000 | 0.08% |
Apr 23, 2024 | Global Retirement Partners, LLC | added | 68.42 | 3,651 | 6,727 | -% |
Apr 22, 2024 | RAYMOND JAMES & ASSOCIATES | reduced | -19.79 | 813,374 | 7,850,980 | -% |
Unveiling Tenet Healthcare Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Tenet Healthcare Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 449.3B | 371.6B | 20.08 | 1.21 | ||||
CI | 103.0B | 195.3B | 19.17 | 0.53 | ||||
CVS | 85.3B | 357.8B | 10.21 | 0.24 | ||||
HCA | 84.4B | 65.0B | 16.11 | 1.3 | ||||
CNC | 40.8B | 154.0B | 15.09 | 0.26 | ||||
DVA | 11.6B | 12.1B | 16.83 | 0.96 | ||||
UHS | 11.5B | 14.3B | 16.03 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 9.3B | 2.3B | 34.28 | 4.13 | ||||
ACHC | 6.6B | 2.9B | -303.23 | 2.24 | ||||
AMN | 2.2B | 3.8B | 10.28 | 0.57 | ||||
AMEH | 2.1B | 1.4B | 33.78 | 1.48 | ||||
SMALL-CAP | ||||||||
ADUS | 1.5B | 1.1B | 24.79 | 1.46 | ||||
BKD | 1.3B | 3.0B | -6.76 | 0.42 | ||||
BEAT | 54.0M | - | -3.69 | - | ||||
AMS | 19.1M | 21.3M | 35.87 | 0.9 |
Tenet Healthcare Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 6.2% | 5,379 | 5,066 | 5,082 | 5,021 | 4,990 | 4,801 | 4,638 | 4,745 | 4,856 | 4,894 | 4,954 | 4,781 | 4,915 | 4,557 | 3,648 | 4,520 | 4,806 | 4,568 | 4,560 | 4,545 | 4,619 |
EBITDA Margin | 4.6% | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.17* | 0.19* | 0.19* | 0.19* | 0.20* | 0.15* | 0.15* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 0% | 227 | 227 | 226 | 221 | 219 | 222 | 222 | 227 | 221 | 227 | 235 | 240 | 242 | 263 | 255 | 243 | 243 | 244 | 247 | 251 | 246 |
Income Taxes | -20.3% | 63.00 | 79.00 | 80.00 | 84.00 | 47.00 | 112 | 86.00 | 99.00 | 108 | 197 | 61.00 | 45.00 | 130 | -197 | 45.00 | -75.00 | 85.00 | 22.00 | 33.00 | 20.00 | 53.00 |
Earnings Before Taxes | 50.4% | 519 | 345 | 373 | 380 | 321 | 380 | 265 | 378 | 528 | 774 | 319 | 267 | 676 | -304 | 214 | 85.00 | 209 | -125 | 152 | 84.00 | 148 |
EBT Margin | 11.8% | 0.08* | 0.07* | 0.07* | 0.07* | 0.07* | 0.08* | 0.10* | 0.10* | 0.10* | 0.10* | 0.05* | 0.05* | - | - | - | - | - | - | - | - | - |
Net Income | 71.4% | 456 | 266 | 293 | 296 | 274 | 268 | 179 | 280 | 419 | 578 | 257 | 222 | 546 | -106 | 169 | 159 | 124 | -146 | 121 | 72.00 | 102 |
Net Income Margin | 13.9% | 0.06* | 0.06* | 0.06* | 0.05* | 0.05* | 0.06* | 0.08* | 0.08* | 0.08* | 0.08* | 0.05* | 0.05* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 88.4% | 616 | 327 | 466 | 214 | 131 | 150 | -33.00 | 73.00 | 53.00 | 321 | 123 | 413 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 2.6% | 28,312 | 27,590 | 27,157 | 27,067 | 27,156 | 27,076 | 26,621 | 26,650 | 27,579 | 25,913 | 26,565 | 27,579 | 27,106 | 26,187 | 26,250 | 23,823 | 23,365 | 23,357 | 23,207 | 23,158 | 22,430 |
Current Assets | 12.7% | 7,167 | 6,359 | 5,995 | 5,869 | 5,981 | 5,998 | 6,064 | 6,128 | 1,176 | 6,905 | 7,417 | 6,699 | 1,309 | 7,808 | 7,947 | 5,388 | 1,180 | 4,789 | 4,704 | 4,582 | 842 |
Cash Equivalents | 16.5% | 1,228 | 1,054 | 934 | 766 | 858 | 1,208 | 1,351 | 1,405 | 2,364 | 2,292 | 2,194 | 2,141 | 2,446 | 3,300 | 3,514 | 613 | 262 | 314 | 249 | 252 | 411 |
Inventory | -0.5% | 411 | 413 | 404 | 407 | 405 | 394 | 387 | 391 | 384 | 376 | 364 | 368 | 368 | 349 | 337 | 324 | 310 | 311 | 309 | 308 | 305 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,001 | 6,995 | 6,996 | 6,993 |
Goodwill | -1.0% | 10,307 | 10,415 | 10,350 | 10,258 | 10,123 | 707 | 206 | 84.00 | 9,261 | 65.00 | 76.00 | 25.00 | 1,581 | 78.00 | 76.00 | 83.00 | 7,252 | 34.00 | 18.00 | 3.00 | 220 |
Liabilities | 1.8% | 22,804 | 22,409 | 22,156 | 22,262 | 22,548 | 22,501 | 22,510 | 22,236 | 23,322 | 22,230 | 23,362 | 23,546 | 24,217 | 24,186 | 24,056 | 21,794 | 21,422 | 21,393 | 21,028 | 21,045 | 20,302 |
Current Liabilities | 7.4% | 4,760 | 4,432 | 4,152 | 4,219 | 4,476 | 4,276 | 4,368 | 4,668 | 495 | 5,379 | 5,071 | 4,930 | 516 | 5,843 | 5,585 | 4,095 | 372 | 3,928 | 4,150 | 3,725 | 313 |
Long Term Debt | -0.1% | 14,882 | 14,901 | 14,907 | 14,935 | 14,934 | 14,962 | 14,947 | 14,719 | 15,511 | 14,009 | 15,091 | 15,098 | 15,574 | 15,561 | 15,728 | 15,082 | 14,580 | 14,858 | 14,312 | 14,814 | 14,644 |
Shareholder's Equity | 9.8% | 1,608 | 1,464 | 2,724 | 2,580 | 1,142 | 2,507 | 2,114 | 2,056 | 2,054 | 1,635 | 1,169 | 1,016 | 937 | 522 | 633 | 503 | 437 | 448 | 670 | 618 | 624 |
Retained Earnings | 56.0% | -192 | -436 | -537 | -660 | -803 | -905 | -1,036 | -1,074 | -1,214 | -1,463 | -1,912 | -2,031 | -2,128 | -2,542 | -2,346 | -2,434 | -2,513 | -2,469 | -2,237 | -2,254 | -2,236 |
Additional Paid-In Capital | 0.3% | 4,834 | 4,818 | 4,800 | 4,774 | 4,778 | 4,771 | 4,756 | 4,765 | 4,877 | 4,862 | 4,854 | 4,841 | 4,844 | 4,826 | 4,751 | 4,739 | 4,760 | 4,751 | 4,755 | 4,748 | 4,747 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,645 | 5,526 | 5,382 | 5,221 |
Shares Outstanding | 0.1% | 102 | 102 | 102 | 102 | 107 | 108 | 108 | 107 | 107 | 107 | 107 | 106 | - | - | - | - | - | - | - | - | - |
Minority Interest | 6.7% | 1,509 | 1,414 | 1,381 | 1,347 | 1,317 | 1,272 | 1,027 | 1,000 | 659 | 913 | 908 | 893 | 621 | 896 | 890 | 861 | 579 | 830 | 825 | 808 | 530 |
Float | - | - | - | 6,400 | - | - | - | 5,600 | - | - | - | 5,400 | - | - | - | 1,100 | - | - | - | 1,200 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 63.8% | 824 | 503 | 598 | 449 | 421 | 315 | 119 | 228 | 357 | 432 | 245 | 534 | 446 | 593 | 2,239 | 129 | 520 | 419 | 284 | 10.00 | 250 |
Share Based Compensation | 20.0% | 18.00 | 15.00 | 19.00 | 14.00 | 9.00 | 13.00 | 18.00 | 16.00 | 13.00 | 13.00 | 16.00 | 14.00 | 6.00 | 11.00 | 14.00 | 13.00 | 8.00 | 11.00 | 12.00 | 11.00 | 12.00 |
Cashflow From Investing | -97.0% | -333 | -169 | -181 | -286 | -306 | -302 | -140 | -60.00 | -1,516 | 997 | -50.00 | -145 | -1,202 | -117 | -85.00 | -204 | -193 | -123 | -164 | -139 | -235 |
Cashflow From Financing | -48.1% | -317 | -214 | -249 | -255 | -465 | -156 | -33.00 | -1,127 | 1,231 | -1,331 | -142 | -694 | -98.00 | -690 | 747 | 426 | -379 | -231 | -123 | -30.00 | -104 |
Buy Backs | - | 110 | - | 40.00 | 50.00 | 250 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net operating revenues | $ 20,548 | $ 19,174 | $ 19,485 |
Grant income | 16 | 194 | 191 |
Equity in earnings of unconsolidated affiliates | 228 | 216 | 218 |
Operating expenses: | |||
Salaries, wages and benefits | 9,146 | 8,844 | 8,878 |
Supplies | 3,590 | 3,273 | 3,328 |
Other operating expenses, net | 4,515 | 3,998 | 4,206 |
Depreciation and amortization | 870 | 841 | 855 |
Impairment and restructuring charges, and acquisition-related costs | 137 | 226 | 85 |
Litigation and investigation costs | 47 | 70 | 116 |
Net gains on sales, consolidation and deconsolidation of facilities | (23) | (1) | (445) |
Operating income | 2,510 | 2,333 | 2,871 |
Interest expense | (901) | (890) | (923) |
Other non-operating income, net | 19 | 10 | 14 |
Loss from early extinguishment of debt | (11) | (109) | (74) |
Income from continuing operations, before income taxes | 1,617 | 1,344 | 1,888 |
Income tax expense | (306) | (344) | (411) |
Income from continuing operations, before discontinued operations | 1,311 | 1,000 | 1,477 |
Discontinued operations: | |||
Income (loss) from operations | 0 | 1 | (1) |
Income (loss) from discontinued operations, net of tax | 0 | 1 | (1) |
Net income | 1,311 | 1,001 | 1,476 |
Less: Net income available to noncontrolling interests | 700 | 590 | 562 |
Net income available to Tenet Healthcare Corporation common shareholders | 611 | 411 | 914 |
Amounts available to Tenet Healthcare Corporation common shareholders: | |||
Income from continuing operations, net of tax | 611 | 410 | 915 |
Income (loss) from discontinued operations, net of tax | 0 | 1 | (1) |
Net income available to Tenet Healthcare Corporation common shareholders | $ 611 | $ 411 | $ 914 |
Basic | |||
Continuing operations (in dollars per share) | $ 6.01 | $ 3.83 | $ 8.56 |
Discontinued operations (in dollars per share) | 0 | 0.01 | (0.01) |
Total earnings (loss) per share, Basic (in dollars per share) | 6.01 | 3.84 | 8.55 |
Diluted | |||
Continuing operations (in dollars per share) | 5.71 | 3.78 | 8.43 |
Discontinued operations (in dollars per share) | 0 | 0.01 | (0.01) |
Total earnings (loss) per share, Diluted (in dollars per share) | $ 5.71 | $ 3.79 | $ 8.42 |
Weighted average shares and dilutive securities outstanding (in thousands): | |||
Basic (in shares) | 101,639 | 106,929 | 106,833 |
Diluted (in shares) | 104,800 | 110,516 | 108,571 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,228 | $ 858 |
Accounts receivable | 2,914 | 2,943 |
Inventories of supplies, at cost | 411 | 405 |
Assets held for sale | 775 | 0 |
Other current assets | 1,839 | 1,775 |
Total current assets | 7,167 | 5,981 |
Investments and other assets | 3,157 | 3,147 |
Deferred income taxes | 77 | 19 |
Property and equipment, at cost, less accumulated depreciation and amortization ($6,478 at December 31, 2023 and $6,201 at December 31, 2022) | 6,236 | 6,462 |
Goodwill | 10,307 | 10,123 |
Other intangible assets, at cost, less accumulated amortization ($1,447 at December 31, 2023 and $1,428 at December 31, 2022) | 1,368 | 1,424 |
Total assets | 28,312 | 27,156 |
Current liabilities: | ||
Current portion of long-term debt | 120 | 145 |
Accounts payable | 1,408 | 1,504 |
Accrued compensation and benefits | 930 | 778 |
Professional and general liability reserves | 254 | 255 |
Accrued interest payable | 200 | 213 |
Liabilities held for sale | 69 | 0 |
Other current liabilities | 1,779 | 1,581 |
Total current liabilities | 4,760 | 4,476 |
Long-term debt, net of current portion | 14,882 | 14,934 |
Professional and general liability reserves | 792 | 790 |
Defined benefit plan obligations | 335 | 331 |
Deferred income taxes | 326 | 217 |
Other long-term liabilities | 1,709 | 1,800 |
Total liabilities | 22,804 | 22,548 |
Commitments and contingencies | ||
Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,391 | 2,149 |
Shareholders’ equity: | ||
Common stock, $0.05 par value; authorized 262,500 shares; 157,271 shares issued at December 31, 2023 and 156,462 shares issued at December 31, 2022 | 8 | 8 |
Additional paid-in capital | 4,834 | 4,778 |
Accumulated other comprehensive loss | (181) | (181) |
Accumulated deficit | (192) | (803) |
Common stock in treasury, at cost, 57,321 shares at December 31, 2023 and 54,215 shares at December 31, 2022 | (2,861) | (2,660) |
Total shareholders’ equity | 1,608 | 1,142 |
Noncontrolling interests | 1,509 | 1,317 |
Total equity | 3,117 | 2,459 |
Total liabilities and equity | $ 28,312 | $ 27,156 |